Michael Narkewicz, MD
Pediatric Gastroenterology
Locations
Practice Locations
Children's Hospital Colorado Anschutz Medical Campus
720-777-1234
Provider Expertise
Clinical Interest for Patients
I am nationally recognized for my expertise in pediatric hepatology and liver transplantation and cystic fibrosis liver disease. I have additional interests in chronic viral hepatitis, pediatric acute liver failure and chronic pancreatitis. I work closely with patients and families to find the best approaches to care to meet their needs.
Specialties
- Pediatrics ( 1988 )
- Pediatric Transplant Hepatology ( 2007 , 2017 )
- Pediatric Gastroenterology ( 1990 , 2016 )
Conditions & Treatments
-
Digestive System
Gastroenterology (Stomach, Bowel, General GI Problems), Hepatology (Liver Disorders)
-
Surgery
Liver Transplant
Interests & Activities
Volunteer Activities
Round Up River Ranch volunteer physician. Medical Advisory Committee: Round Up River Ranch Chair, Medical Advisory Committee: American Liver Foundation
Education & Training
Medical Schools
MD, University of Vermont College of Medicine (1983)
Undergraduate Schools
AB, Dartmouth College (NH) (1979)
Residency Program
University of Colorado (1986)
Fellowships
University of Colorado (1989)
Professional Memberships
American Academy of Pediatrics (AAP), Fellow AAP
American Association for the Study of Liver Disease (AASLD), Fellow Member
American Pediatric Society, Member
North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN), Member
Research & Grants
Grants
Prospective Study of Hepatic US to Predict Cirrhosis In Cystic Fibrosis (2020)
A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function (The PROMISE Study) (2020)
A phase 2, open-label , multicenter, multi-cohort study to investigate the safety and efficacy of sofosbuvir/velpatasvir in adolescents and children with chronic HCV-infection (2020)
Pilot study of proteomics and metabolomics as part of the CFLD NET PUSH Longitudinal Study of Cystic Fibrosis Liver Disease. (2020)
CFF PUSH cohort analysis using MRI to characterize and predict CF liver disease (2020)
Long Term Follow-up Registry for Adolescent and Pediatric Subjects Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials (2020)
A Randomized Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide (TAF) in Adolescents with Chronic Hepatitis B Virus Infection. (2020)
Research Interests for Patients
My research focuses on new therapies for children with hepatitis B and C. I lead a large study that is trying to develop tests that will predict which patients with cystic fibrosis are at risk for the development of advanced liver disease
information for referring providers
Referral Contact Phone
(720) 777-6669
Clinical Interests for Referring Providers
I am interested in pediatric hepatology, liver transplantation, chronic viral hepatitis, pediatric acute liver failure, cystic fibrosis associated liver disease, and health care delivery.
Research Interest for Referring Providers
My research interests include clinical studies in children with biliary atresia, clinical trials and transmission in chronic viral hepatitis, hematologic and immunologic complications following pediatric liver transplantation, improved diagnosis and treatment of cystic fibrosis-associated liver disease, and clinical trials in acute liver failure.
